What three decades of metabolic surgery have actually taught me.

What 30 years of metabolic surgery have taught me

Patients change. Procedures change. The biology of obesity has not.

When I began operating in the early 1990s, bariatric surgery was a fringe specialty. The patients I see in 2026 — sometimes the children of patients I operated on in the 2000s — arrive with a different vocabulary, a different set of expectations, and access to GLP-1 medications I did not have available for most of my career. What has not changed is the underlying biology of obesity and the lifelong nature of metabolic disease.

The single most important lesson of three decades is humility about long-term outcomes. A perfect operation at 10:00 a.m. on a Tuesday does not guarantee a perfect result ten years later. The patient does that work, every day, with our help.

Common misconceptions about obesity

Five framings that still hurt patients — and what the evidence actually says.

Obesity is not a moral failing, a lack of willpower, or the result of one bad decade. It is a chronic, relapsing, multifactorial disease with genetic, hormonal, environmental, and behavioral components. Treating it as anything less is bad medicine.

The most damaging misconception in my consult room is still the idea that 'real' patients should be able to fix this on their own. They cannot — not because they are weak, but because human metabolism does not work that way.

How bariatric surgery has evolved

From open Roux-en-Y in the 1990s to laparoscopic sleeve, banding, revision, and the GLP-1 era.

The arc of the field — open to laparoscopic, then to robotic; banding to sleeve to bypass; surgery alone to surgery plus pharmacotherapy — has been faster than most surgical subspecialties. Each step has reduced morbidity and broadened candidacy.

The next decade will be about integration: choosing the right combination of medication, surgery, and behavioral support for each patient, then following that patient for life.

Lessons from thousands of operations

What a 19,801-patient series teaches that a single case cannot.

Volume teaches pattern recognition that single cases cannot. The OCC–UCSD review of 19,801 procedures (2000–2021) reported a 30-day morbidity rate of 1.2% and zero mortalities. Behind that number is a thousand small decisions about anesthesia, ERAS protocols, instrument selection, and team training.

Outcomes at scale come from systems, not heroics.

Why long-term follow-up matters

The operation is the easy part. The next twenty years are the medicine.

Patients lost to follow-up are patients we cannot help. Weight regain, nutritional deficiencies, and metabolic drift are all manageable when they are caught at month six instead of year five.

Our most successful patients are not the ones who lost the most weight in the first year. They are the ones who came back.

When surgery is not the right answer

Three categories of patients I send home without scheduling an operation.

Untreated psychiatric illness, active substance use, and unrealistic expectations are the three most common reasons I decline to operate. Surgery is a powerful tool, not a universal one. A patient who is not ready will not benefit from being pushed.

Saying no, clearly and kindly, is part of the job.

What successful patients have in common

Five years out, what separates the patients who thrive.

They eat deliberately. They move. They keep their follow-up appointments. They treat the operation as a tool and not a cure. Most importantly, they have a community — family, peers, or our long-term follow-up program — that holds them accountable in a loving way.

The future of obesity medicine

What the next decade will look like — and what it will demand of clinicians.

Personalized combinations of pharmacotherapy and surgery. AI-augmented decision-making. Better long-term metabolic monitoring. And, critically, a much wider definition of what 'treatment' includes — closer to the chronic-disease model we already use for diabetes or hypertension.

The surgeons who thrive in that environment will be the ones who think like internists.